Form 13-F position report

AERIE PHARMACEUTICALS INC

Reported by GEODE CAPITAL MANAGEMENT LLC

AERI CUSIP 00771V108 Manager CIK 0001214717

Reported 0 shares, down 862,809 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 37 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 5884000
2022-03-31 6949000
2022-06-30 6265000
2022-09-30 13054000
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for AERIE PHARMACEUTICALS INC held by GEODE CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -862,809 (-100.0%) 0 $0 2023-02-13
Q3 2022 Added 862,809 +27,423 (3.3%) < 0.01% $13,054,000 2022-11-14
Q2 2022 Added 835,386 +71,654 (9.4%) < 0.01% $6,265,000 2022-08-12
Q1 2022 Reduced 763,732 -74,581 (-8.9%) < 0.01% $6,949,000 2022-05-13
Q4 2021 Added 838,313 +184,703 (28.3%) < 0.01% $5,884,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

153 managers reported AERIE PHARMACEUTICALS INC for Q4 2022.

Managers reporting AERIE PHARMACEUTICALS INC in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
PINNACLE ASSOCIATES LTD Reduced 0 -964,759 0 $0 14 qtrs
NATIXIS ADVISORS L P Reduced 0 -37,375 0 $0 9 qtrs
Virtu Financial LLC Reduced 0 -25,101 0 $0 2 qtrs
The Goldman Sachs Group Inc Reduced 0 -939,811 0 $0 35 qtrs
DAFNA Capital Management LLC Reduced 0 -307,232 0 $0 34 qtrs
NEW YORK STATE COMMON RETIREMENT FUND Reduced 0 -61,094 0 $0 31 qtrs
Qube Research & Technologies Ltd Reduced 0 -221,266 0 $0 2 qtrs
PenderFund Capital Management Ltd Reduced 0 -22,950 0 $0 2 qtrs
Jump Financial LLC Reduced 0 -45,846 0 $0 4 qtrs
BCK Capital Management LP Reduced 0 -64,000 0 $0 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 13, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.